Literature DB >> 11355306

Neuronal nitric oxide synthase immunoreactivity in the spinal cord in amyotrophic lateral sclerosis.

S Sasaki1, N Shibata, M Iwata.   

Abstract

We investigated the spinal cords of 15 patients with sporadic amyotrophic lateral sclerosis (ALS) immunohistochemically using an anti-human neuronal nitric oxide synthase (nNOS) antibody to examine whether there is increased nNOS immunoreactivity in anterior horn neurons. Specimens from 16 patients without any neurological disease served as controls. In the controls, nNOS immunoreactivity of large anterior horn neurons was detected in 10 out of 16 cases. However, there were few nNOS-positive neurons, and most of large anterior horn neurons were spared. In the ALS patients, the mean number of nNOS-positive anterior horn neurons per transverse section of L4 and L5 was significantly larger (16.2 +/- 10.9) than that in the controls (7.0 +/- 9.2) (P < 0.0001). Moreover, 41.4% of large anterior horn neurons in ALS showed nNOS immunoreactivity in remarkable contrast to 7.6% in the controls. All ALS patients, whether showing mild, moderate or severe depletion of anterior horn neurons, displayed a higher percentage of nNOS-positive anterior horn neurons than the control patients showing nNOS immunoreactivity (P < 0.01). Most of the remaining anterior horn neurons in ALS showed more intense nNOS immunoreactivity on the surface of the neurons and their neuronal processes compared with the controls. Degenerated anterior horn neurons frequently demonstrated more intense nNOS immunoreactivity on the surface of the neurons than normal-appearing neurons. Some anterior horn cells displayed nNOS immunoreactivity in the somata. Dot-like nNOS deposits on anterior horn neurons were also positively immunoreactive with anti-synaptophysin antibody. Thus, increased nNOS expression is located mainly at the synaptic sites on the anterior horn neurons in sporadic ALS, which may be related to the degeneration of anterior horn neurons in this disease. Further studies are needed to determine whether the increased nNOS immunoreactivity plays a neuroprotective or neurotoxic role in the anterior horn neurons, and to show nitric oxide production in ALS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11355306     DOI: 10.1007/s004010000282

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  5 in total

Review 1.  Research progress on neurobiology of neuronal nitric oxide synthase.

Authors:  Chun-Xia Luo; Dong-Ya Zhu
Journal:  Neurosci Bull       Date:  2011-02       Impact factor: 5.203

Review 2.  NO orchestrates the loss of synaptic boutons from adult "sick" motoneurons: modeling a molecular mechanism.

Authors:  Bernardo Moreno-López; Carmen R Sunico; David González-Forero
Journal:  Mol Neurobiol       Date:  2010-12-29       Impact factor: 5.590

Review 3.  Nitric oxide-mediated oxidative damage and the progressive demise of motor neurons in ALS.

Authors:  Derek A Drechsel; Alvaro G Estévez; Luis Barbeito; Joseph S Beckman
Journal:  Neurotox Res       Date:  2012-04-10       Impact factor: 3.911

4.  Nitric oxide induces pathological synapse loss by a protein kinase G-, Rho kinase-dependent mechanism preceded by myosin light chain phosphorylation.

Authors:  Carmen R Sunico; David González-Forero; Germán Domínguez; José Manuel García-Verdugo; Bernardo Moreno-López
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

5.  Inducible nitric oxide synthase is present in motor neuron mitochondria and Schwann cells and contributes to disease mechanisms in ALS mice.

Authors:  Kevin Chen; Frances J Northington; Lee J Martin
Journal:  Brain Struct Funct       Date:  2009-11-04       Impact factor: 3.270

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.